16694-44-3 Purity
96%
If you have any other questions or need other size, please get a quote.
Reference: [1]Current Patent Assignee: VIFOR PHARMA LTD - US2013/109662, 2013, A1
Location in patent: Paragraph 0375; 0376; 0377; 0378; 0379; 0380
[2]Beger, J.; Thielemann, C.
[Journal fur praktische Chemie (Leipzig 1954), 1981, vol. 323, # 2, p. 337 - 344]
[3]Boido; Novelli; Savelli; Sparatore; Russo; Filippelli; Susanna; Marmo
[Il Farmaco, 1989, vol. 44, # 3, p. 279 - 301]
[4]Current Patent Assignee: DOW INC - US2152132, 1936, A
Reference: [1]Kinoshita, Toshio; Takeuchi, Kozue; Kondoh, Masaya; Furukawa, Sunao
[Chemical and pharmaceutical bulletin, 1989, vol. 37, # 8, p. 2026 - 2029]
Reference: [1]Torosyan, G. O.; Gekchyan, G. G.; Babayan, A. T.
[Journal of Organic Chemistry USSR (English Translation), 1982, vol. 18, p. 1423 - 1426][Zhurnal Organicheskoi Khimii, 1982, vol. 18, # 8, p. 1628 - 1632]
[2]Torosyan, G. O.; Gekchyan, G. G.; Babayan, A. T.
[Journal of Organic Chemistry USSR (English Translation), 1982, vol. 18, p. 1423 - 1426][Zhurnal Organicheskoi Khimii, 1982, vol. 18, # 8, p. 1628 - 1632]
[3]Couturier,P. et al.
[Bulletin de la Societe Chimique de France, 1962, p. 594 - 595]
* For details of the synthesis route, please refer to the original source to ensure accuracy.